214 related articles for article (PubMed ID: 32658799)
1. Juvenile recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: Initial report.
Rojas-Lechuga MJ; Remacha J; González-Sánchez N; Grau JJ; Castillo P; Haag O; Vilaseca I
Int J Pediatr Otorhinolaryngol; 2020 Oct; 137():110194. PubMed ID: 32658799
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of microsurgery in combined with topical-PDT in treating recurrent respiratory papillomatosis: compare JORRP with AORRP.
Yang S; Zhou C; Sun B; Wang F; Han Z; Zhang H; Han J; Shen Y; Zhang J
Acta Otolaryngol; 2019 Dec; 139(12):1133-1139. PubMed ID: 31556770
[No Abstract] [Full Text] [Related]
3. Constitutive overexpression of the oncogene Rac1 in the airway of recurrent respiratory papillomatosis patients is a targetable host-susceptibility factor.
Lucs AV; Wu R; Mullooly V; Abramson AL; Steinberg BM
Mol Med; 2012 Mar; 18(1):244-9. PubMed ID: 22113496
[TBL] [Abstract][Full Text] [Related]
4. Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy.
Limsukon A; Susanto I; Soo Hoo GW; Dubinett SM; Batra RK
Chest; 2009 Sep; 136(3):924-926. PubMed ID: 19736197
[TBL] [Abstract][Full Text] [Related]
5. Prolonged remission of juvenile-onset respiratory papillomatosis: a post-expositional role of the tetravalent anti-HPV vaccine?
Yi L; Vaudaux B; Sandu K; Nisa L
Int J Pediatr Otorhinolaryngol; 2014 Feb; 78(2):388-90. PubMed ID: 24388316
[TBL] [Abstract][Full Text] [Related]
6. Recurrent respiratory papillomatosis: A state-of-the-art review.
Fortes HR; von Ranke FM; Escuissato DL; Araujo Neto CA; Zanetti G; Hochhegger B; Souza CA; Marchiori E
Respir Med; 2017 May; 126():116-121. PubMed ID: 28427542
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis.
Avelino MA; Zaiden TC; Gomes RO
Braz J Otorhinolaryngol; 2013; 79(5):636-42. PubMed ID: 24141682
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of juvenile-onset recurrent respiratory papillomatosis.
Xiao Y; Zhang X; Ma L; Wang J
Clin Otolaryngol; 2021 Jan; 46(1):161-167. PubMed ID: 32815263
[TBL] [Abstract][Full Text] [Related]
10. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
11. Systemic bevacizumab for recurrent respiratory papillomatosis.
Baday YI; Ongkasuwan J; Venkatramani R
Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110352. PubMed ID: 32906078
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.
Sullivan C; Curtis S; Mouzakes J
Int J Pediatr Otorhinolaryngol; 2017 Feb; 93():103-106. PubMed ID: 28109479
[TBL] [Abstract][Full Text] [Related]
13. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience.
So RJ; Rayle C; Joo HH; Huang EY; Seiwert TY; Raabe EH; Best SR
Laryngoscope; 2024 Jul; 134(7):3253-3259. PubMed ID: 38525973
[TBL] [Abstract][Full Text] [Related]
14. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes of recurrent respiratory papillomatosis : Retrospective analysis of juvenile and adult cases.
Papaioannou VA; Lux A; Voigt-Zimmermann S; Arens C
HNO; 2018 Jan; 66(Suppl 1):7-15. PubMed ID: 28840259
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy for recurrent respiratory papillomatosis.
Lieder A; Khan MK; Lippert BM
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009810. PubMed ID: 24898010
[TBL] [Abstract][Full Text] [Related]
17. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study.
Novakovic D; Cheng AT; Cope DH; Brotherton JM
Sex Health; 2010 Sep; 7(3):253-61. PubMed ID: 20719212
[TBL] [Abstract][Full Text] [Related]
18. Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis.
Bentley PL; Coulter MJ; Nelson BL
Head Neck Pathol; 2019 Jun; 13(2):235-238. PubMed ID: 29594918
[TBL] [Abstract][Full Text] [Related]
19. Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey.
Best SR; Mohr M; Zur KB
Laryngoscope; 2017 Oct; 127(10):2225-2229. PubMed ID: 28657692
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus Vaccination as an Adjuvant Therapy for Recurrent Respiratory Papillomatosis: Additional Case Series.
Matsuzaki H; Makiyama K; Hasegawa H; Asai R; Morita M; Oshima T
J Voice; 2024 Jan; 38(1):204-209. PubMed ID: 34600799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
